Results Based Grants
Examples of successful grant applications include:
Ethical Apparel Africa
EAA, a sourcing and manufacturing company, is poised to scale its operations by winning and fulfilling orders in its factory, Maagrace and through partner SME factories in Accra. However, a systemic constraint—limited access to industrial engineering expertise—hinders these factories from meeting the quality and efficiency standards required to compete in the UK market.
Strategic Implementation
Leveraging the programme’s RBGs, EAA successfully embedded an international lean consultant into Maagrace and other SMEs’ technical capabilities to secure additional orders and expand Ghana’s footprint in high-value export markets. The initiative will be scaled sustainably through a train-the-trainer model, embedding expert knowledge in each factory and ensuring long-term industrial competency.
Impact and Future Vision
Integrating an international lean consultant into Maagrace and partner SME factories has already yielded efficiency improvements, as identified through milestone monitoring. This intervention addresses Ghana’s systemic constraint—the lack of industrial engineering expertise—by embedding technical capabilities that enhance production quality, reduce waste, and improve turnaround times. Though still in progress, these efficiency gains lay the foundation for a sector-wide frontier shift, transitioning Ghana’s garment manufacturing from low-margin, dependency-driven exports to a self-sustaining, globally competitive industry.
Atlantic Life Sciences (ALS)
Atlantic Life Sciences (ALS) is a Ghanaian pharmaceutical company focused on local drug manufacturing to meet domestic and international market demands. Africa lacks WHO PQ-certified pharmaceutical companies, which limits local medicine production and increases dependence on costly imports. Without PQ certification, manufacturers cannot compete for global procurement contracts, restricting growth and weakening health security.
Intervention & Capacity Building
ALS was supported through the programme’s grant facility to invite a WHO Prequalification (PQ) documentation expert to train ALS staff, equipping them with the skills and competencies required to develop essential manuals for the PQ process. The consultant provided hands-on guidance and capacity-building to empower ALS staff to generate required documentation moving forward independently. This initiative drives a frontier shift by elevating ALS’s compliance capacity to meet WHO PQ standards, a critical benchmark for global pharmaceutical markets. By embedding structured GMP processes and building in-house expertise, ALS moved from limited documentation capabilities to a self-sustaining system that ensures long-term regulatory alignment.